Gross Law Firm Urges ImmunityBio Shareholders to Act Before Lead Plaintiff Deadline
The Gross Law Firm Urges Action: Lead Plaintiff Deadline Approaches for ImmunityBio, Inc.
In a critical reminder to shareholders, The Gross Law Firm has issued an alert concerning the upcoming lead plaintiff deadline for investors of ImmunityBio, Inc. (NASDAQ: IBRX). The firm encourages all shareholders who acquired shares of IBRX from January 19, 2026, to March 24, 2026, to consider their options in this significant class-action lawsuit. The deadline for registering as a lead plaintiff is set for May 26, 2026.
Understanding the Allegations
The class-action complaint indicates that during the specified period, ImmunityBio was accused of making materially misleading statements about its product, Anktiva, and its business operations. More specifically, the allegations assert that Soon-Shion misrepresented the capabilities of Anktiva, potentially leading investors to form false perceptions regarding the company's prospects. This misrepresentation raises concerns about accountability and transparency within the company.
Why Should Shareholders Act?
Shareholders are urged not to delay in registering for the class action, as participation does not require appointment as the lead plaintiff. To register and get more information, shareholders can visit the transitional link provided by The Gross Law Firm. Additionally, once registered, investors will have the benefit of monitoring tools to receive updates throughout the case's lifecycle.
The Gross Law Firm is recognized nationally for its commitment to safeguarding the rights of investors, particularly those affected by deceitful practices and misinformation in the market. Their mission is clear – to hold companies accountable for their actions and ensure fair treatment towards all shareholders.
Next Steps for Shareholders
To participate, shareholders need to navigate to the dedicated registration page for the ImmunityBio lawsuit. Here, they will be prompted to submit their information, which is crucial for monitoring cases and obtaining updates on any progress made. Importantly, there are no costs associated with signing up, making this an accessible option for all concerned investors.
Contacting The Gross Law Firm
For any further inquiries, shareholders can reach out to The Gross Law Firm directly at their New York office. Whether through an email or a phone call, the firm is prepared to assist investors in understanding their rights and the implications of the lawsuit.
In conclusion, the upcoming deadline serves as a crucial reminder for ImmunityBio shareholders to take action. Staying informed and engaged can significantly influence the outcome of this class action lawsuit and protect investment interests.
Important Details
- - Class Period: January 19, 2026 – March 24, 2026
- - Lead Plaintiff Deadline: May 26, 2026
- - Firm Contact: The Gross Law Firm
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903
Stay proactive and ensure your voice is heard in this pivotal moment in ImmunityBio’s history.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.